MedPath

Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior?

Not Applicable
Completed
Conditions
Colorectal Cancer
Registration Number
NCT03819920
Lead Sponsor
Stanford University
Brief Summary

This study is designed to examine the impact of telephone-based colorectal cancer risk assessment on colorectal screening attitudes and behavior among previously unscreened adults ages 50 to 75.

Detailed Description

Colorectal cancer (CRC) remains the 3rd most common cancer in the US. Most CRCs are preventable, but screening participation remains suboptimal. Several factors have been associated with screening compliance, such as perception of CRC risk. Here we study the impact of telephone-based administration of the National Cancer Institute Colorectal Cancer Risk Assessment Tool (CCRAT) compared to usual care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
229
Inclusion Criteria
  • Patient of any participating physician
  • Not having had any colorectal cancer screening test prior
  • Able to speak English
Exclusion Criteria
  • Personal history of inflammatory bowel disease
  • Personal history of colorectal cancer
  • Personal history of Lynch syndrome or Familial Adenomatous Polyposis
  • Have already received colorectal cancer screening

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Screening Behavior: Differences in colorectal cancer screening completion rates between usual care (UC) and CCRAT12 months after intervention

Any CRC screening test completed including stool tests (FOBT (fecal occult blood test), FIT (immunochemical test for fecal blood), stool DNA test), colonoscopy, flexible sigmoidoscopy, double contrast barium enema, CT colonography (virtual colonoscopy)

Secondary Outcome Measures
NameTimeMethod
Screening Behavior: Differences in colorectal cancer screening completion rates between usual care (UC) and CCRAT6 months after intervention

Any CRC screening test completed including stool tests (FOBT (fecal occult blood test), FIT (immunochemical test for fecal blood), stool DNA test), colonoscopy, flexible sigmoidoscopy, double contrast barium enema, CT colonography (virtual colonoscopy)

Colorectal cancer screening rates at 12 months as a function of CCRAT score12 months after intervention

Screening completion at 12 months will be compared between the 3 tertiles of CCRAT score in the intervention group to determine whether there is any relationship between absolute CCRAT score and screening completion

Change in intention to screen at 6 months and 12 monthsImmediate after intervention, 6 months and 1 year after intervention

Differences in progressive behavioral stages of adoption from precontemplation to contemplation to preparation.

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

Stanford University School of Medicine
🇺🇸Palo Alto, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.